Total Payments
$996.03
2021 Payments
$38.43
Companies
10
Transactions
50
Medicare Patients
3,459
Medicare Billing
$185,296
Payment Breakdown by Category
Food & Beverage$996.03 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $996.03 | 50 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $379.83 | 18 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $212.97 | 9 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $101.56 | 7 | $0 (2021) |
| Cardiovascular Systems Inc. | $91.70 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $85.55 | 6 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $44.97 | 3 | $0 (2018) |
| PFIZER INC. | $40.21 | 3 | $0 (2020) |
| Esperion Therapeutics, Inc. | $13.37 | 1 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $13.23 | 1 | $0 (2018) |
| Novo Nordisk Inc | $12.64 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $38.43 | 2 | Amgen Inc. ($21.90) |
| 2020 | $64.00 | 4 | Amgen Inc. ($19.27) |
| 2019 | $161.06 | 10 | Amgen Inc. ($76.44) |
| 2018 | $465.28 | 21 | Amgen Inc. ($207.85) |
| 2017 | $267.26 | 13 | Novartis Pharmaceuticals Corporation ($151.81) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/18/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Cardiology | ||||||
| 03/19/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/28/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/23/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/12/2020 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Cardiology | ||||||
| 01/24/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Diabetes | ||||||
| 10/10/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Cardiology | ||||||
| 08/22/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.81 | General |
| Category: Cardiovascular | ||||||
| 07/10/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Cardiology | ||||||
| 06/27/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/25/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Cardiology | ||||||
| 04/12/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/21/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/15/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/06/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Cardiology | ||||||
| 11/28/2018 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Cardiology | ||||||
| 11/07/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/02/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| Category: Cardiovascular | ||||||
| 10/18/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $109.07 | General |
| Category: Cardiology | ||||||
| 09/19/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.09 | General |
| Category: Cardiovascular | ||||||
| 09/19/2018 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: Cardiology | ||||||
| 08/30/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/23/2018 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Cardiology | ||||||
| 08/15/2018 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 11 | 959 | 1,260 | $161,365 | $56,235 |
| 2020 | 13 | 2,500 | 3,480 | $359,609 | $129,061 |
Total Patients
3,459
Total Services
4,740
Medicare Billing
$185,296
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 226 | 251 | $47,600 | $21,624 | 45.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 71 | 89 | $22,425 | $11,218 | 50.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 48 | 233 | $19,805 | $5,990 | 30.2% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 21 | 21 | $17,850 | $3,534 | 19.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $7,020 | $3,129 | 44.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $5,940 | $2,812 | 47.3% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 44 | 44 | $7,920 | $2,478 | 31.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 212 | 221 | $14,365 | $2,197 | 15.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 248 | 312 | $10,920 | $2,063 | 18.9% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg, includes recording, scanning analysis with report | Office | 2021 | 19 | 19 | $5,700 | $893.20 | 15.7% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 13 | 13 | $910.00 | $177.90 | 19.5% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 13 | 13 | $910.00 | $118.70 | 13.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 435 | 524 | $91,700 | $41,445 | 45.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 176 | 219 | $51,684 | $24,032 | 46.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 231 | 240 | $43,200 | $14,352 | 33.2% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 70 | 481 | $40,885 | $14,116 | 34.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 841 | 1,173 | $41,055 | $8,065 | 19.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 46 | 46 | $15,180 | $7,276 | 47.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 447 | 531 | $34,515 | $6,565 | 19.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 42 | 42 | $11,340 | $5,438 | 48.0% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Office | 2020 | 43 | 45 | $13,500 | $2,801 | 20.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 20 | 22 | $5,390 | $2,403 | 44.6% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 69 | 70 | $4,900 | $1,227 | 25.0% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2020 | 69 | 70 | $4,900 | $822.41 | 16.8% |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 fo | Office | 2020 | 11 | 17 | $1,360 | $520.26 | 38.3% |
About Dr. Robert Bennett, M.D
Dr. Robert Bennett, M.D is a Cardiovascular Disease healthcare provider based in Tappahannock, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821039496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Bennett, M.D has received a total of $996.03 in payments from pharmaceutical and medical device companies, with $38.43 received in 2021. These payments were reported across 50 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($996.03).
As a Medicare-enrolled provider, Bennett has provided services to 3,459 Medicare beneficiaries, totaling 4,740 services with total Medicare billing of $185,296. Data is available for 2 years (2020–2021), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Tappahannock, VA
- Active Since 06/08/2006
- Last Updated 10/30/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1821039496
Products in Payments
- Corlanor (Drug) $228.44
- ENTRESTO (Drug) $212.97
- Repatha (Biological) $151.39
- ELIQUIS (Drug) $125.76
- XARELTO (Drug) $101.56
- Peripheral Orbital Atherectomy System (Device) $91.70
- MULTAQ (Drug) $44.97
- NEXLETOL (Drug) $13.37
- JANUVIA (Drug) $13.23
- Ozempic (Drug) $12.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.